Valuation: Camurus AB

Market Cap 36.6B 3.82B 3.33B 3.07B 2.82B 5.36B 367B 5.45B 14.36B 180B 14.34B 14.02B 624B P/E 2026 *
33.4x
P/E 2027 * 21.3x
Enterprise Value 31.95B 3.33B 2.9B 2.68B 2.46B 4.68B 321B 4.76B 12.53B 157B 12.51B 12.24B 544B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 8.18x
Free-Float
67.52%
Yield 2026 *
-
Yield 2027 * -
1 day+16.81%
1 week+6.40%
Current month+8.75%
1 month+14.10%
3 months+15.28%
6 months-10.80%
Current year-0.16%
1 week 525.5
Extreme 525.5
624
1 month 505
Extreme 505
624
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 275
Extreme 275
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
02-27Sell

Chief Executive Officer

1,500 0.0025%
02-27Sell

Chief Executive Officer

9,950 0.0166%
02-27Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
+16.81%+6.40%-10.48%+123.80% 3.25B
+0.35%-6.39%+44.70%+157.34% 1,028B
-2.69%-7.57%+57.52%+54.51% 611B
+0.44%-4.14%+27.46%+79.48% 432B
+0.98%-2.74%+28.13%+21.76% 323B
-0.34%-3.79%+26.52%+43.60% 277B
+1.63%-12.52%+17.86%+21.72% 257B
+3.39%+0.95%-25.43%-37.83% 217B
+0.86%-2.66%+20.63%+57.55% 192B
+1.28%-3.42%+17.49%+70.62% 161B
Average +2.59%-5.61%+20.44%+59.25% 350.16B
Weighted average by Cap. +0.71%-5.52%+32.91%+76.75%

Financials

2026 *2027 *
Net sales 2.81B 293M 256M 236M 217M 412M 28.22B 418M 1.1B 13.79B 1.1B 1.08B 47.9B 3.77B 393M 343M 316M 290M 552M 37.83B 561M 1.48B 18.49B 1.48B 1.44B 64.21B
Net income 954M 99.57M 86.78M 80.11M 73.53M 140M 9.58B 142M 374M 4.68B 374M 366M 16.27B 1.45B 152M 132M 122M 112M 213M 14.58B 216M 570M 7.13B 569M 556M 24.75B
Net Debt -4.65B -485M -423M -390M -358M -681M -46.68B -692M -1.82B -22.81B -1.82B -1.78B -79.23B -5.78B -603M -526M -486M -446M -847M -58.08B -861M -2.27B -28.38B -2.27B -2.22B -98.57B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
15/07/26 SEK 615.00 +16.81% 380,833
14/07/26 SEK 526.50 -2.05% 69,616
13/07/26 SEK 537.50 -3.07% 72,062
10/07/26 SEK 554.50 +0.82% 101,864
09/07/26 SEK 550.00 -1.52% 95,389
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
615.00SEK
Average target price
771.88SEK
Spread / Average Target
+25.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock